Join the 'Rejection Reversal' group to help and get support from people like you.
Rejection Reversal News
Posted 29 Sep 2015 by Drugs.com
TUESDAY, Sept. 29, 2015 – Living near busy roads with high levels of air pollution raises lung transplant patients' risk of organ rejection and death, but some antibiotics lower that risk, a new study shows. Researchers examined data gathered from more than 5,700 lung transplant patients in 10 European countries between 1987 and 2013. The analysis revealed that patients who lived in areas where air pollution was above maximum levels recommended by the World Health Organization (WHO) were 10 percent more likely to die than those in areas with lower levels of pollution. But this increased risk of death was not seen among patients who took a class of antibiotics called macrolides, which include azithromycin (Zithromax) and clarithromycin (Biaxin), according to the study presented Tuesday at a meeting of the European Respiratory Society in Amsterdam. "Short and long-term exposure to air ... Read more
Related support groups: Azithromycin, Zithromax, Erythromycin, Clarithromycin, Upper Respiratory Tract Infection, Biaxin, Immunosuppression, Zithromax Z-Pak, MY-E, Organ Transplant - Rejection Prophylaxis, Z-Pak, Erythrocin, Respiratory Tract Disease, Immunodeficiency, Ery-Tab, Organ Transplant, Biaxin XL, Respiratory Distress Syndrome, Organ Transplant - Rejection Reversal, Pulmonary Impairment
Posted 7 Mar 2012 by Drugs.com
WEDNESDAY, March 7 – Researchers report that they were able to create a kind of hybrid immune system in patients who received kidney transplants, a process that appeared to allow the recipients' bodies to accept a foreign organ instead of trying to reject it. There are caveats. The research is preliminary and only involved a tiny number of patients. Also, the required procedure is expensive and its long-term effects aren't known. But if it works, the process – which involves transferring bone marrow cells from the kidney donor to the patient – could allow organ transplant recipients to avoid a lifetime of taking dozens of pills a day. "It's a huge step forward," said Dr. Suzanne Ildstad, director of the University of Louisville's Institute for Cellular Therapeutics, and co-author of the study published in the March 7 issue of Science Translational Medicine. The immune system's job is ... Read more